Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA †
Titel:
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA †
Auteur:
Krop, I.E. Lin, N.U. Blackwell, K. Guardino, E. Huober, J. Lu, M. Miles, D. Samant, M. Welslau, M. Diéras, V.